ATT 1 Senior _Advisor_2026_Statement of Work - Biological therapeutics EOC Support- 7571PS27Q00017

COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: 2 Senior Advisor Consultants for the NINDS BPN -Biologics program External Oversight Committee (EOC) Subject Matter Expert (SME) Services (i) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with RFO Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 7571PS27Q00017 issued as a Request for Quote for 2 Senior Advisor Consultants for the NINDS BPN -Biologics program External Oversight Committee (EOC) Subject Matter Expert (SME) Services The Government reserves the right to make one award, multiple awards, or no awards as a result of this solicitation. This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov . The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (ii) This requirement is for the following services: NINDS is seeking [VW1] 2 Senior Advisor Consultants for the NINDS BPN -Biologics program External Oversight Committee (EOC) Subject Matter Expert (SME) Services. (iii) Description of requirement: The NIH is seeking to procure a highly experienced executive-level , drug discovery and development 2 Senior Advisors with experience in the area of biological therapeutics to provide feedback to the NIH program leadership and technical guidance on drug discovery and development projects within the BPN-Biologics portfolio. The Contractor will serve as a member of the BPN-Biologics External Oversight Committee, which provides strategic guidance on BPN-Biologics projects and on occasion other NIH drug discovery and development programs. See Attachment #1 - Statement of Work (SOW) for more information. (iv) The Government anticipates awar